• Study of AZD0486 plus rituximab versus standard chemotherapy drug combination in previously untreated follicular lymphoma patients

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    Denmark
  • Evaluation of Trazodone Hydrochloride for Improving Emotional Blunting in Patients with Major Depressive Disorder

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria Hungary Poland
  • Safety and efficacy of obinutuzumab in patients with active diffuse systemic sclerosis: a randomized, double-blind, placebo-controlled trial

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    France
  • Phase Ib/II study of momelotinib with nivolumab or pembrolizumab in unresectable stage III/IV cutaneous melanoma

    Not yet recruiting

    1 1 1 1
    Investigated Drugs:
    Sweden
  • Serum Transthyretin Levels in Patients with Transthyretin Amyloid Cardiomyopathy Treated with Tafamidis and Acoramidis: A Within‑Patient Pilot Crossover Study

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria
  • Efficacy and Safety of Daily Subcutaneous Elamipretide Trihydrochloride Injections in Patients with Barth Syndrome (Phase 3b/4 Randomized Trial)

    Not yet recruiting

    3 1
    France Ireland Italy The Netherlands
  • Safety and feasibility study of CARCIK‑CD123/33 cell therapy in adult and pediatric patients with relapsed or refractory AML and BPDCN

    Not yet recruiting

    2 1 1
    Italy
  • Intrapleural Alteplase and Dornase Alfa versus VATS for Patients with Pleural Empyema (Parapneumonic Pleural Infection)

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    The Netherlands
  • Apixaban for Preventing Blood Clots in Adults Receiving Neoadjuvant Therapy for Muscle‑Invasive Bladder Cancer

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Finland
  • Safety and Pharmacodynamics of RBD4059 and Apixaban in Patients with Non‑Valvular Atrial Fibrillation: A Randomized Active‑Controlled Study

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark Norway Poland Sweden

powered by